海昇药业
(920656)
| 流通市值：11.93亿 | | | 总市值：14.61亿 |
| 流通股本：8162.86万 | | | 总股本：1.00亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 419,637,677.44 | 436,052,547.46 | 380,610,266.95 | 57,685,701.55 |
| 交易性金融资产 | - | - | 55,216,333 | 360,000,000 |
| 应收票据及应收账款 | 29,444,415.25 | 33,174,020.65 | 26,310,111.99 | 36,290,427.56 |
| 应收账款 | 29,444,415.25 | 33,174,020.65 | 26,310,111.99 | 36,290,427.56 |
| 应收款项融资 | 26,068,054.6 | 17,861,503.2 | 5,546,649.25 | 5,130,185.33 |
| 预付款项 | 353,969.95 | 560,240.5 | 1,596,687.51 | 1,424,056.27 |
| 其他应收款合计 | 163,068.09 | 192,000.35 | 211,516.15 | 237,092.44 |
| 存货 | 35,152,847.92 | 33,098,696.68 | 33,872,013.65 | 27,414,684.07 |
| 其他流动资产 | - | - | 428,340.07 | 624,274.79 |
| 流动资产合计 | 510,820,033.25 | 520,939,008.84 | 503,791,918.57 | 488,806,422.01 |
| 非流动资产: | | | | |
| 固定资产 | 122,030,498.73 | 125,781,987.67 | 130,022,429.03 | 124,679,947.33 |
| 在建工程 | 84,477,995.49 | 79,448,156.17 | 78,785,754.69 | 67,491,569 |
| 无形资产 | 22,435,030.64 | 21,528,121.89 | 21,736,024.47 | 21,943,927.05 |
| 长期待摊费用 | 63,670.89 | 107,783.4 | 151,895.91 | 196,008.42 |
| 递延所得税资产 | 1,099,822.63 | 1,174,493.43 | 1,126,934.43 | 386,045.52 |
| 其他非流动资产 | 414,655 | 1,408,026.23 | 1,261,088.86 | 2,208,836.98 |
| 非流动资产合计 | 230,521,673.38 | 229,448,568.79 | 233,084,127.39 | 216,906,334.3 |
| 资产总计 | 741,341,706.63 | 750,387,577.63 | 736,876,045.96 | 705,712,756.31 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 16,057,392.64 | 13,499,550.4 | 19,089,457.35 | 8,231,684.86 |
| 应付账款 | 16,057,392.64 | 13,499,550.4 | 19,089,457.35 | 8,231,684.86 |
| 合同负债 | 456,593.96 | 55,135.19 | 1,050,524.41 | 1,520,538.57 |
| 应付职工薪酬 | 351,693.85 | - | - | 22,157.55 |
| 应交税费 | 6,450,163.78 | 5,699,723.95 | 5,651,033.67 | 4,976,582.83 |
| 其他应付款合计 | 2,022,223.07 | 2,064,800 | 2,089,906.44 | 2,133,133.71 |
| 其他流动负债 | 18,999.29 | 10,870.34 | 95,404.12 | 348,612.62 |
| 流动负债合计 | 25,357,066.59 | 21,330,079.88 | 27,976,325.99 | 17,232,710.14 |
| 非流动负债: | | | | |
| 递延收益 | 5,100,063.01 | 5,277,618.23 | 5,455,173.45 | 5,781,310.25 |
| 非流动负债合计 | 5,100,063.01 | 5,277,618.23 | 5,455,173.45 | 5,781,310.25 |
| 负债合计 | 30,457,129.6 | 26,607,698.11 | 33,431,499.44 | 23,014,020.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 |
| 资本公积 | 325,928,888.87 | 325,885,657.75 | 325,838,558.35 | 325,501,556.02 |
| 专项储备 | 332,559.3 | 199,720.37 | 3,966.73 | 4,785.28 |
| 盈余公积 | 48,372,632.75 | 48,372,632.75 | 48,372,632.75 | 41,426,934.4 |
| 未分配利润 | 236,250,496.11 | 249,321,868.65 | 229,229,388.69 | 215,765,460.22 |
| 归属于母公司股东权益合计 | 710,884,577.03 | 723,779,879.52 | 703,444,546.52 | 682,698,735.92 |
| 股东权益合计 | 710,884,577.03 | 723,779,879.52 | 703,444,546.52 | 682,698,735.92 |
| 负债和股东权益合计 | 741,341,706.63 | 750,387,577.63 | 736,876,045.96 | 705,712,756.31 |
| 公告日期 | 2026-08-20 | 2026-04-16 | 2026-04-16 | 2025-10-27 |
| 审计意见(境内) | | | 标准无保留意见 | |